Provider
QP31-21 Update for New to Market Medical Drugs: Avalglucosidase Alfa and Selexipag (Uptravi intravenous formulation)
Program effective Date: Apr 14, 2021
Documents & Forms Results
Displaying 1341 - 1350 of 3680 results
Provider
QP28-21 Commercial Pharmacy Benefit Exclusion for Select Medications and Formulary Alternatives
Program effective Date: Apr 14, 2021
Provider
QP70-21 Commercial Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective November 1, 2021
Program effective Date: Sep 08, 2021
Provider
QP65R1-21 Update: Minnesota Health Care Programs Providers use of the Interactive Care Reviewer
Program effective Date: Sep 08, 2021
Provider
QP69-21 Update for New to Market Medical Drugs: Ciltacabtagene Autoleucel
Program effective Date: Sep 08, 2021
Provider
2021 September Bulletins
Program effective Date: Sep 01, 2021
Provider
P49-21 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Program effective Date: Sep 01, 2021